News

A cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...
University of Southern California researchers have found a way to rebrand this oft-embarrassing sore subject by genetically ...
Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...
Genital Herpes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current genital herpes marketed drugs ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
Modified Herpes Virus as a Weapon Against Skin Cancer? A new study suggests it might work—even for metastases deep within the ...
The herpes simplex virus type 1 (HSV-1), which affects almost two-thirds of the world's population and is generally ...
With few real-life studies that have specifically focused on how atopic dermatitis (AD) affects patients living with the ...
One-in-six patients treated with the modified virus as part of a clinical trial saw their tumors disappear completely.
Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.